Beijing Winsunny Pharmaceutical CO.LTD (601089) — Working Capital to Net Assets Ratio
Beijing Winsunny Pharmaceutical CO.LTD (601089) has a Working Capital to Net Assets ratio of 50.6% as of June 2025. Working capital of CN¥1.82 Billion (current assets of CN¥2.87 Billion minus current liabilities of CN¥1.05 Billion) is measured against net assets of CN¥3.59 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Beijing Winsunny Pharmaceutical CO.LTD free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Beijing Winsunny Pharmaceutical CO.LTD Working Capital to Net Assets (2020–2024)
This chart shows how Beijing Winsunny Pharmaceutical CO.LTD's Working Capital to Net Assets ratio has evolved across 5 annual periods from 2020 to 2024. As of June 2025, the ratio stands at 50.6%, reflecting working capital of CN¥1.82 Billion against net assets of CN¥3.59 Billion CNY. See operational self-sufficiency of Beijing Winsunny Pharmaceutical CO.LTD to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Beijing Winsunny Pharmaceutical CO.LTD (2020–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Beijing Winsunny Pharmaceutical CO.LTD from 2020 to 2024, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Beijing Winsunny Pharmaceutical CO.LTD (601089) market capitalisation.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 56.6% | CN¥2.01 Billion | CN¥3.56 Billion | CN¥3.20 Billion | CN¥1.19 Billion | ▼ -10.5 pp |
| 2023 | 67.0% | CN¥2.33 Billion | CN¥3.48 Billion | CN¥3.33 Billion | CN¥998.38 Million | ▼ -5.9 pp |
| 2022 | 73.0% | CN¥2.32 Billion | CN¥3.18 Billion | CN¥3.37 Billion | CN¥1.05 Billion | ▲ +39.0 pp |
| 2021 | 34.0% | CN¥412.94 Million | CN¥1.22 Billion | CN¥1.28 Billion | CN¥866.48 Million | ▼ -4.2 pp |
| 2020 | 38.2% | CN¥385.08 Million | CN¥1.01 Billion | CN¥1.07 Billion | CN¥688.70 Million | — |